Market closedADR
Novartis/$NVS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Novartis
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Ticker
$NVS
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Basel, Switzerland
Employees
76,057
Website
Novartis Metrics
BasicAdvanced
$194B
Market cap
11.28
P/E ratio
$8.58
EPS
0.51
Beta
$2.43
Dividend rate
2.51%
Dividend yield
Price and volume
Market cap
$194B
Beta
0.51
52-week high
$120.06
52-week low
$92.35
Average daily volume
1.2M
Dividend rate
$2.43
Financial strength
Current ratio
1.111
Quick ratio
0.782
Long term debt to equity
58.346
Total debt to equity
74.029
Dividend payout ratio (TTM)
43.31%
Interest coverage (TTM)
19.33%
Management effectiveness
Return on assets (TTM)
10.59%
Return on equity (TTM)
28.79%
Valuation
Price to earnings (TTM)
11.281
Price to revenue (TTM)
3.943
Price to book
4.02
Price to tangible book (TTM)
-18.29
Price to free cash flow (TTM)
15.687
Dividend yield (TTM)
2.51%
Forward dividend yield
2.51%
Growth
Revenue change (TTM)
8.92%
Earnings per share change (TTM)
130.53%
3-year revenue growth (CAGR)
-1.58%
3-year earnings per share growth (CAGR)
25.61%
3-year dividend per share growth (CAGR)
4.94%
What the Analysts think about Novartis
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Novartis stock.
Novartis Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Novartis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Novartis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Novartis stock?
Novartis (NVS) has a market cap of $194B as of December 21, 2024.
What is the P/E ratio for Novartis stock?
The price to earnings (P/E) ratio for Novartis (NVS) stock is 11.28 as of December 21, 2024.
Does Novartis stock pay dividends?
Yes, the Novartis (NVS) stock pays dividends to shareholders. As of December 21, 2024, the dividend rate is $2.4307 and the yield is 2.51%. Novartis has a payout ratio of 43.31% on a trailing twelve-month basis.
When is the next Novartis dividend payment date?
The next Novartis (NVS) dividend payment date is unconfirmed.
What is the beta indicator for Novartis?
Novartis (NVS) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.